Fertin Pharma

Vejle, Denmark Founded: 1915 • Age: 111 yrs Acquired By Philip Morris International
Medicated chewing gum for pharmaceuticals is developed and manufactured.

About Fertin Pharma

Fertin Pharma is a company based in Vejle (Denmark) founded in 1915 was acquired by Philip Morris International in July 2021.. Fertin Pharma has raised $962.11 thousand across 3 funding rounds from investors including Philip Morris International, EQT and IFU. Fertin Pharma offers products and services including Zapliq®, Compressed gum, Extruded gum, Lozenge, and Pouches. Fertin Pharma operates in a competitive market with competitors including PharmaJet, Arecor, Suono Bio, Ensysce and Renovis, among others.

  • Headquarter Vejle, Denmark
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Fertin Pharma A/S
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
    $-108.06 (USD)
    30
    as on Dec 31, 2022
  • EBITDA
  • Total Equity Funding
    $962.11 K (USD)

    in 3 rounds

  • Latest Funding Round
    $962.11 K (USD), Private Equity Round

    Jun 01, 2014

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Philip Morris International

    & 1 more

    (Jul 01, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Fertin Pharma

Fertin Pharma offers a comprehensive portfolio of products and services, including Zapliq®, Compressed gum, Extruded gum, Lozenge, and Pouches. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Liquid-based system for effective pharmaceutical delivery.

Gum format for targeted active ingredient release.

Custom gum for nutraceutical applications.

Dissolvable form for pain and allergy management.

Container for vitamins and supplements delivery.

Chewable option for energy and sleep aids.

People of Fertin Pharma
Headcount 500-1000
Employee Profiles 32
Employee Profiles
People
Signe From
Sustainability Project Manager
People
Gifford E. Rogers III
Principal Packaging Development Engineer
People
Lykke Anderson
Laboratory Technician
People
Eva Jacobsen
Senior Manager

Unlock access to complete

Funding Insights of Fertin Pharma

Fertin Pharma has successfully raised a total of $962.11K across 3 strategic funding rounds. The most recent funding activity was a Private Equity Round round of $962.11 thousand completed in June 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Private Equity Round — $962,108
  • First Round

    (16 Jul 2008)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2014 Amount Debt – Conventional - Fertin Pharma Valuation

investors

IFU
Jun, 2014 Amount Private Equity Round - Fertin Pharma Valuation IFU
Jul, 2008 Amount Grant - Fertin Pharma Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Fertin Pharma

Fertin Pharma has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Philip Morris International, EQT and IFU. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Private equity investment firm
Founded Year Domain Location
EQT is recognized as a global investment organization focused on value creation.
Founded Year Domain Location
Administers health care and support for military personnel and operations.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Fertin Pharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Fertin Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Fertin Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Fertin Pharma

Fertin Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PharmaJet, Arecor, Suono Bio, Ensysce and Renovis, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of needle-free injection technology
domain founded_year HQ Location
Developer of proteins, vaccines based on proprietary stabilization technologies for drug delivery
domain founded_year HQ Location
Developer of technology to enable ultra-rapid delivery of therapeutics to the gastrointestinal tract
domain founded_year HQ Location
Drug delivery solutions via single-walled carbon nanotubes are offered.
domain founded_year HQ Location
Drugs for neurological diseases are discovered and developed.
domain founded_year HQ Location
Provider of a proprietary platform for gene therapy
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Fertin Pharma

Philip Morris International acquires Fertin Pharma for $ 820m
Pharmaceutical-Technology4 years ago
Philip Morris to acquire Fertin Pharma for $ 812.8m
Pharmaceutical-Business-Review4 years ago

Frequently Asked Questions about Fertin Pharma

When was Fertin Pharma founded?

Fertin Pharma was founded in 1915 and raised its 1st funding round 93 years after it was founded.

Where is Fertin Pharma located?

Fertin Pharma is headquartered in Vejle, Denmark.

Who is the current CEO of Fertin Pharma?

Soren Birn is the current CEO of Fertin Pharma.

Is Fertin Pharma a funded company?

Fertin Pharma is a funded company, having raised a total of $962.11K across 3 funding rounds to date. The company's 1st funding round was a Grant of $101.4K, raised on Jul 16, 2008.

What does Fertin Pharma do?

Fertin Pharma was established in 1915 in Vejle, Denmark, within the pharmaceutical sector. Medicated chewing gum is developed and produced for various applications, utilizing a patented multi-layered compressed technology known as Medichew. Additional offerings include nutraceuticals, oral care items, multivitamins, and related products, with operations centered on manufacturing and innovation in oral delivery systems.

Who are the top competitors of Fertin Pharma?

Fertin Pharma's top competitors include Oxular, PharmaJet and Splice Bio.

What products or services does Fertin Pharma offer?

Fertin Pharma offers Zapliq®, Compressed gum, Extruded gum, Lozenge, and 2 more products and services.

Who are Fertin Pharma's investors?

Fertin Pharma has 4 investors. Key investors include Philip Morris International, EQT, IFU, and Military Health.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available